Healthcare Jul 06, 2020 11:46 AM (GMT+8) · EqualOcean
NeoX Biotech, a Beijing-based startup, announced it completed Series Pre-A fundraising of tens of millions of dollars. The investment was co-led by Vision Plus Capital and Sequoia Seed Fund (China), participated by the serial Morningside Venture Capital. The bankroll will help neoX Biotech expand its talent team, build the high-throughput laboratories and promote R&D pipelines. The biotech company hopes to use AI computing work as a pushing engine in the R&D industry based on the computability of the biological system and protein-protein interactions (PPI).